Form 4: Clover Health CEO Jamie Reynoso Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Jamie Reynoso, CEO of Medicare Advantage at Clover Health, sold shares of Class A Common Stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

  • On October 3, 2024, Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 8,706 shares of Class A Common Stock.
  • The shares were sold at a price of $4.
  • This transaction was to cover tax obligations related to the vesting of 6.25% of restricted stock units (RSUs) granted on January 3, 2023.
  • Following the transaction, Reynoso still beneficially owns 2,745,739 shares of Class A Common Stock directly.
  • The remaining RSUs will vest in equal quarterly installments until January 3, 2027, contingent upon continued service.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock transactions by a company insider to cover tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The remaining RSUs will vest in equal quarterly installments until January 3, 2027, contingent upon continued service of the Reporting Person.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in company stock. This transaction is related to tax obligations arising from vesting equity, which is a common occurrence.

Key Dates

DateDescription
January 3, 2023Date of original grant of restricted stock units (RSUs) to Jamie Reynoso.
January 5, 2023Date of Form 4 filing reporting the original grant of RSUs.
October 3, 2024Date of transaction where shares were withheld to cover tax obligations due to RSU vesting.
October 7, 2024Date of signature on the Form 4 filing.
January 3, 2027Final vesting date for the remaining RSUs.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.